朝聚眼科医疗控股有限公司（02219）于2026年10月6日发布翌日披露报表，宣布当日于香港联交所场内回购股份4.45万股，占公司已发行股本约0.0063%。本次回购的最高成交价为每股2.39港元，最低成交价为每股2.375港元，合计付出约10.60万港元。
根据公告，截至2026年10月6日，公司已发行股本总数为701,460,000股，暂无库藏股。公司购回授权于2026年5月12日获得股东大会通过，可回购股份总数为70,518,050股，截至目前，公司已合共回购6,304,500股，占购回授权通过日已发行股份数目的约0.894%。
公司确认本次回购已严格遵守香港联交所证券上市规则及相关法律规定。公告由执行董事兼联席公司秘书张光弟签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.